TFF3 facilitates dormancy of anti-estrogen treated ER+ mammary carcinoma
Abstract Background Tumor dormancy is a substantial clinical obstacle in treatment of estrogen receptor positive mammary carcinoma (ER+MC), contributing to drug resistance, metastatic outgrowth, relapse, and consequent mortality. Methods Preclinical models mimicking clinical anti-estrogen-induced ER...
-д хадгалсан:
| Үндсэн зохиолчид: | , , , , , |
|---|---|
| Формат: | Artigo |
| Хэл сонгох: | Inglês |
| Хэвлэсэн: |
Nature Portfolio
2025-02-01
|
| Цуврал: | Communications Medicine |
| Онлайн хандалт: | https://doi.org/10.1038/s43856-024-00710-9 |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|